Increase in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreAIFA's restructuring in Italy aims to streamline drug approval, replacing committees and introducing...
Read moreAIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...
Read moreDiscover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...
Read moreCollectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreIt is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...
Read moreThe National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...
Read moreThe Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...
Read moreIn 2026, U.S. policy shifts will link domestic US prices to internatio...
Read more2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...
Read more